J. Goldman & Co’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.57M | Buy |
42,584
+14,111
| +50% | +$1.18M | 0.09% | 173 |
|
|
2025
Q1 | $2.03M | Sell |
28,473
-16,869
| -37% | -$1.21M | 0.05% | 194 |
|
|
2024
Q4 | $2.04M | Buy |
45,342
+23,570
| +108% | +$1.06M | 0.05% | 207 |
|
|
2024
Q3 | $1.1M | Sell |
21,772
-5,166
| -19% | -$261K | 0.03% | 194 |
|
|
2024
Q2 | $1.1M | Buy |
+26,938
| New | +$1.1M | 0.03% | 198 |
|
|
2024
Q1 | – | Sell |
-73,252
| Closed | -$2.95M | – | 384 |
|
|
2023
Q4 | $2.95M | Buy |
73,252
+7,252
| +11% | +$292K | 0.12% | 108 |
|
|
2023
Q3 | $1.95M | Sell |
66,000
-54,799
| -45% | -$1.62M | 0.07% | 136 |
|
|
2023
Q2 | $518K | Sell |
120,799
-148,644
| -55% | -$638K | 0.02% | 189 |
|
|
2023
Q1 | $577K | Buy |
269,443
+156,944
| +140% | +$336K | 0.02% | 179 |
|
|
2022
Q4 | $223K | Buy |
112,499
+67,500
| +150% | +$134K | 0.01% | 230 |
|
|
2022
Q3 | $75K | Buy |
+44,999
| New | +$75K | ﹤0.01% | 247 |
|
|
2021
Q1 | – | Sell |
-7,992
| Closed | -$231K | – | 411 |
|
|
2020
Q4 | $231K | Sell |
7,992
-8,140
| -50% | -$235K | 0.01% | 247 |
|
|
2020
Q3 | $607K | Sell |
16,132
-10,360
| -39% | -$390K | 0.04% | 174 |
|
|
2020
Q2 | $882K | Buy |
26,492
+17,083
| +182% | +$569K | 0.05% | 145 |
|
|
2020
Q1 | $336K | Sell |
9,409
-4,479
| -32% | -$160K | 0.04% | 147 |
|
|
2019
Q4 | $612K | Buy |
+13,888
| New | +$612K | 0.04% | 136 |
|